Key Takeaways Resmed reports Q2 FY26 on Jan. 29, with consensus projecting 8.3% year-over-year revenue growth.RMD likely benefited from strong mask demand, new AirTouch launches, NightOwl adoption and AirSense sales.Resmed's software unit may see gains from MEDIFOX, Brightree and MatrixCare despite SNF market pressure.Resmed (RMD) is set to release its second-quarter fiscal 2026 results on Jan. 29, after the closing bell. The renowned sleep health device maker posted adjusted earnings per share (EPS) of $2. ...